MedTrace Logo

Non-automatic Control of Gait and Posture in Obstructive Sleep Apnea Syndrome (CIH-Gait)

NCT02345694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-03-18

No results posted yet for this study

Summary

The purpose of this randomised controlled study is to determine the impact of continuous positive airway pressure (CPAP) versus sub-therapeutic CPAP (placebo) on the control of gait upon severe sleep apnea patients, based on stride time variability.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

Effective CPAP

Effective Continuous Positive Airway Pressure auto-regulated, worn all night long during 8 weeks

DEVICE

Sub-therapeutic CPAP

Sub-therapeutic Continuous Positive Airway Pressure (Sham-CPAP) worn all night long during 8 weeks

Sponsors & Collaborators

  • Agence Régionale de Santé Rhône-Alpes

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Bernard WUYAM, MD, PhD · University Hospital, Grenoble

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-03
Primary Completion
2018-11-28
Completion
2018-12-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02345694 on ClinicalTrials.gov